• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙拉里奥哈地区BRCA1和BRCA2基因的分子分析:五个新变体

Molecular analysis of BRCA1 and BRCA2 genes in La Rioja (Spain): five new variants.

作者信息

Salazar Saez Raquel, Zorrilla Miriam, Sánchez Rosa, Cebollero Ana, Manrique Isabel, Martín Alfonso, de Ávila Leticia, Lacalle-Emborujo Alejandra, Martin-Rodriguez Samuel, Bernardo-González Iván, Alonso Martina

机构信息

Clinical Oncology Unit, Hospital Universitario San Pedro de Logroño, La Rioja, Spain.

Servicio de Oncología Médica, Hospital Universitario San Pedro, 3ª planta, Calle Piqueras nº 98, Logroño, La Rioja, 26006, Spain.

出版信息

Hered Cancer Clin Pract. 2024 Oct 22;22(1):22. doi: 10.1186/s13053-024-00296-2.

DOI:10.1186/s13053-024-00296-2
PMID:39438962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11495111/
Abstract

BACKGROUND

To study BRCA1/2 gene variants in La Rioja in the northcentral area of Spain.

METHODS

We performed a molecular analysis of BRCA1 and BRCA2 in 642 individuals from 427 different families from June 2008 to December 2019.

RESULTS

We identified 71 families with pathogenic variants in these genes, 32 families with BRCA1 variants and 39 families with BRCA2 variants. The pathogenic variants c.959delG in BRCA1 and c.1363_1369delTCAGAGA, c.1397dupA, c.4234_4236delACTinsC and c.8387delC in BRCA2 have not been previously described. The c.81-2 A > T variant in BRCA1, detected in two unrelated families, has not been reported previously in the Spanish population. Two large genomic deletions were found in the BRCA1 gene in exons (Ex) 23-24 and Ex1A-1B-2, and one deletion was found in the BRCA2 gene in Ex2. The pathogenic variant c.5123 C > A in BRCA1 was detected in 8 unrelated families and was the most frequent pathogenic variant in our population. The c.6024dupG mutation in BRCA2 was detected in 6 unrelated families; the c.2808_2011delACAA mutation in BRCA2 was found in 5 different families; the c.211 A > G mutation in BRCA1 was found in three different families; and the c.68_69delAG, c81-2 A > T, c.4038_4039delAA, and c.5266dupC variants in BRCA1 and the c.2457delA, c.2701delC, c.5116_5119delAATA, c.6275delTT, c.7558 C > T and c.7617 + 1G > A variants in BRCA2 were found in two different families.

CONCLUSIONS

The spectrum of pathogenic variants in the BRCA1/2 genes in La Rioja is similar to that in other Spanish regions, with some unique characteristics. The pathogenic c.6024dupG variant in the BRCA2 gene was detected in a large number of families and could have a founding effect in the Ebro riverside areas in the regions of La Rioja and Navarra.

TRIAL REGISTRATION

Not applicable.

摘要

背景

研究西班牙中北部拉里奥哈地区的BRCA1/2基因变异情况。

方法

2008年6月至2019年12月,我们对来自427个不同家庭的642名个体进行了BRCA1和BRCA2的分子分析。

结果

我们在这些基因中鉴定出71个携带致病变异的家庭,其中32个家庭携带BRCA1变异,39个家庭携带BRCA2变异。BRCA1基因中的致病变异c.959delG以及BRCA2基因中的c.1363_1369delTCAGAGA、c.1397dupA、c.4234_4236delACTinsC和c.8387delC此前尚未见报道。在两个无亲缘关系的家庭中检测到的BRCA1基因中的c.81-2 A>T变异,此前在西班牙人群中未见报道。在BRCA1基因的外显子(Ex)23-24和Ex1A-1B-2中发现了两个大的基因组缺失,在BRCA2基因的Ex2中发现了一个缺失。BRCA1基因中的致病变异c.5123 C>A在8个无亲缘关系的家庭中被检测到,是我们研究人群中最常见的致病变异。BRCA2基因中的c.6024dupG突变在6个无亲缘关系的家庭中被检测到;BRCA2基因中的c.2808_2011delACAA突变在5个不同家庭中被发现;BRCA1基因中的c.211 A>G突变在3个不同家庭中被发现;BRCA1基因中的c.68_69delAG、c81-2 A>T、c.4038_4039delAA和c.5266dupC变异以及BRCA2基因中的c.2457delA、c.2701delC、c.5116_5119delAATA、c.6275delTT、c.7558 C>T和c.7617+1G>A变异在两个不同家庭中被发现。

结论

拉里奥哈地区BRCA1/2基因的致病变异谱与西班牙其他地区相似,但有一些独特特征。BRCA2基因中的致病变异c.6024dupG在大量家庭中被检测到,可能在拉里奥哈和纳瓦拉地区的埃布罗河畔地区产生奠基效应。

试验注册

不适用。

相似文献

1
Molecular analysis of BRCA1 and BRCA2 genes in La Rioja (Spain): five new variants.西班牙拉里奥哈地区BRCA1和BRCA2基因的分子分析:五个新变体
Hered Cancer Clin Pract. 2024 Oct 22;22(1):22. doi: 10.1186/s13053-024-00296-2.
2
Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.西班牙东南部穆尔西亚地区遗传性乳腺癌和卵巢癌家族中BRCA1/BRCA2基因变异的分子特征及临床解读:BRCA携带者和非携带者的临床病理特征
Fam Cancer. 2017 Oct;16(4):477-489. doi: 10.1007/s10689-017-9985-x.
3
Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain).BRCA1 和 BRCA2 基因突变分析在来自西班牙阿斯图里亚斯(北部)的遗传性乳腺癌和卵巢癌家族中。
BMC Cancer. 2013 May 17;13:243. doi: 10.1186/1471-2407-13-243.
4
Genetic analysis of BRCA1 and BRCA2 in breast/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1.西班牙阿拉贡地区乳腺癌/卵巢癌家族中BRCA1和BRCA2的基因分析:BRCA1中的两个新的截短突变和一个大的基因组缺失
Breast Cancer Res Treat. 2008 Nov;112(2):353-8. doi: 10.1007/s10549-007-9868-1. Epub 2008 Jan 4.
5
Spectrum and characterisation of BRCA1 and BRCA2 deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer.高危捷克乳腺癌和/或卵巢癌患者中BRCA1和BRCA2有害突变的谱系及特征分析
BMC Cancer. 2008 May 20;8:140. doi: 10.1186/1471-2407-8-140.
6
High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.来自布拉格地区的乳腺癌和卵巢癌患者中,BRCA1基因生殖系突变的复发比例较高。
Breast Cancer Res. 2005;7(5):R728-36. doi: 10.1186/bcr1282. Epub 2005 Jul 19.
7
Landscape of germline variants in breast and ovarian cancer in Peru.秘鲁乳腺癌和卵巢癌种系变异情况
Front Oncol. 2023 Aug 17;13:1227864. doi: 10.3389/fonc.2023.1227864. eCollection 2023.
8
BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.BRCA1 和 BRCA2 未分类变异体及错义多态性在阿尔及利亚乳腺癌/卵巢癌家族中的研究。
Dis Markers. 2012;32(6):343-53. doi: 10.3233/DMA-2012-0893.
9
[Comparison of hereditary breast and ovarian cancer syndrome and sporadic ovarian cancer in ovarian cancer BRCA mutations].[遗传性乳腺癌和卵巢癌综合征与散发性卵巢癌中卵巢癌BRCA突变的比较]
Zhonghua Fu Chan Ke Za Zhi. 2021 Nov 25;56(11):788-795. doi: 10.3760/cma.j.cn112141-20210722-00395.
10
[BRCA1 and BRCA2 mutations in families studied in the program of genetic counselling in cancer of the Valencian community (Spain)].[西班牙巴伦西亚自治区癌症遗传咨询项目中所研究家族的BRCA1和BRCA2基因突变]
Med Clin (Barc). 2008 Feb 9;130(4):121-6. doi: 10.1157/13115767.

本文引用的文献

1
Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain).西班牙纳瓦拉地区 BRCA 相关性遗传性乳腺癌和卵巢癌的遗传和临床特征。
BMC Cancer. 2019 Nov 27;19(1):1145. doi: 10.1186/s12885-019-6277-x.
2
Spectrum and prevalence of germline mutations in Pakistani breast cancer patients: results from a large comprehensive study.巴基斯坦乳腺癌患者种系突变的谱系与患病率:一项大型综合研究的结果
Hered Cancer Clin Pract. 2019 Sep 11;17:27. doi: 10.1186/s13053-019-0125-5. eCollection 2019.
3
Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population.罗马尼亚人群中接受多基因检测的乳腺癌患者有害突变的患病率。
Clujul Med. 2018;91(2):157-165. doi: 10.15386/cjmed-894. Epub 2018 Apr 25.
4
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.BRCA1 或 BRCA2 突变 29700 个家系的世界性研究中的突变谱。
Hum Mutat. 2018 May;39(5):593-620. doi: 10.1002/humu.23406. Epub 2018 Mar 12.
5
and founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile.在智利的遗传性乳腺癌家族中,奠基者突变占胚系携带者的78%。
Oncotarget. 2017 Jun 29;8(43):74233-74243. doi: 10.18632/oncotarget.18815. eCollection 2017 Sep 26.
6
Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations.中美洲和南美洲人群中BRCA1、BRCA2及其他乳腺癌和卵巢癌易感基因的突变
Biol Res. 2017 Oct 6;50(1):35. doi: 10.1186/s40659-017-0139-2.
7
A multi-gene panel study in hereditary breast and ovarian cancer in Colombia.哥伦比亚遗传性乳腺癌和卵巢癌的多基因检测研究
Fam Cancer. 2018 Jan;17(1):23-30. doi: 10.1007/s10689-017-0004-z.
8
Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.西班牙东南部穆尔西亚地区遗传性乳腺癌和卵巢癌家族中BRCA1/BRCA2基因变异的分子特征及临床解读:BRCA携带者和非携带者的临床病理特征
Fam Cancer. 2017 Oct;16(4):477-489. doi: 10.1007/s10689-017-9985-x.
9
PARP inhibitors: Synthetic lethality in the clinic.聚(ADP-核糖)聚合酶抑制剂:临床中的合成致死性
Science. 2017 Mar 17;355(6330):1152-1158. doi: 10.1126/science.aam7344. Epub 2017 Mar 16.
10
BRCA1 p.His1673del is a pathogenic mutation associated with a predominant ovarian cancer phenotype.BRCA1基因第1673位组氨酸缺失(p.His1673del)是一种与主要卵巢癌表型相关的致病突变。
Oncotarget. 2017 Apr 4;8(14):22640-22648. doi: 10.18632/oncotarget.15151.